Literature DB >> 8435378

Torasemide in comparison with thiazides in the treatment of hypertension.

P Baumgart1.   

Abstract

There are a number of clinically relevant differences between torasemide and the thiazide diuretics in the treatment of hypertension. Only 2.5-5 mg torasemide once daily is sufficient for antihypertensive treatment; these low doses of torasemide exert comparable antihypertensive effects to those of the overtly natriuretic doses of thiazides (e.g., hydrochlorothiazide 25 mg) that are currently used once daily for the treatment of hypertension. Whereas natriuretic thiazide doses reduce blood pressure rapidly, the blood pressure-lowering effect of low-dose torasemide appears to occur more gradually during the first weeks of treatment. The diurnal blood pressure rhythm is not altered by either drug. In contrast to the thiazides, torasemide does not cause significant renal potassium loss in doses recommended to treat hypertension. Long-term antihypertensive treatment with torasemide has not resulted in undesired metabolic side effects, such as hypomagnesemia, alterations in glucose and lipid metabolism, or hyperuricemia. As compared with the thiazides, torasemide appears to be a safer and equally effective alternative for antihypertensive treatment when subdiuretic doses of this loop diuretic are used.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435378     DOI: 10.1007/bf00877959

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  18 in total

1.  Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension.

Authors:  Y Lacourcière; P Provencher
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 2.  Metabolic effects of various antihypertensive agents.

Authors:  T O Morgan
Journal:  J Cardiovasc Pharmacol       Date:  1990       Impact factor: 3.105

3.  Antihypertensive efficacy of low dose torasemide in essential hypertension: a placebo-controlled study.

Authors:  A G Dupont; D Schoors; R O Six; L Vanhaelst
Journal:  J Hum Hypertens       Date:  1988-12       Impact factor: 3.012

4.  Antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene.

Authors:  A Kohvakka; H Salo; A Gordin; A Eisalo
Journal:  Acta Med Scand       Date:  1986

Review 5.  Low dose loop diuretics in essential hypertension. Experience with torasemide.

Authors:  I Achhammer; P Metz
Journal:  Drugs       Date:  1991       Impact factor: 9.546

6.  Is low-dose hydrochlorothiazide effective?

Authors:  P F Magee; E D Freis
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

7.  Incidence of cardiac arrhythmias associated with mild hypokalemia induced by low-dose diuretic therapy for hypertension.

Authors:  R W Peters; J Hamilton; B P Hamilton
Journal:  South Med J       Date:  1989-08       Impact factor: 0.954

8.  Hypokalaemia and diuretics: an analysis of publications.

Authors:  D B Morgan; C Davidson
Journal:  Br Med J       Date:  1980-03-29

9.  Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium, and ventricular ectopy.

Authors:  J W Hollifield
Journal:  Am J Med       Date:  1986-04-25       Impact factor: 4.965

10.  Serum lipoprotein levels during chlorthalidone therapy. A Veterans Administration-National Heart, Lung, and Blood Institute cooperative study on antihypertensive therapy: mild hypertension.

Authors:  A I Goldman; B W Steele; H W Schnaper; A E Fitz; E D Frohlich; H M Perry
Journal:  JAMA       Date:  1980-10-10       Impact factor: 56.272

View more
  6 in total

Review 1.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 2.  Personalizing the diuretic treatment of hypertension: the need for more clinical and research attention.

Authors:  Samuel J Mann; Michael E Ernst
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

3.  Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study.

Authors:  Sophie Lochner; Wilhelm Kirch; Christoph Schindler
Journal:  Eur J Clin Pharmacol       Date:  2011-12-30       Impact factor: 2.953

Review 4.  Torasemide. An update of its pharmacological properties and therapeutic efficacy.

Authors:  C J Dunn; A Fitton; R N Brogden
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 5.  Loop Diuretics in the Treatment of Hypertension.

Authors:  Line Malha; Samuel J Mann
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

Review 6.  Benefits and risks of torasemide in congestive heart failure and essential hypertension.

Authors:  D C Brater
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.